Viridian Therapeutics (VRDN) Stock: Buy, Sell, or Hold?
VRDN - Viridian Therapeutics, Inc. Common Stock
$22.82
-0.19 (-0.83%)
▼
5d:
+16.67%
30d:
+6.49%
90d:
+18.42%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 04, 2026
11d
Get Alerted When VRDN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: VRDN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: VRDN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: VRDN is currently trading at $22.82, which is considered extended relative to its 30-day fair value range of $18.79 to $21.99.
Technical Outlook: Technically, VRDN is in a strong uptrend. Immediate support is located at $17.96, while resistance sits at $23.59.
Market Sentiment: VRDN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $36.75 (+61.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VRDN is in a strong uptrend. Immediate support is located at $17.96, while resistance sits at $23.59.
Market Sentiment: VRDN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $36.75 (+61.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.79 -
$21.99
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
26.3%
Protect Your Profits
Holding VRDN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 61.0% below Wall St target ($36.75)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$18.79 -
$21.99
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.96
Resistance Level
$23.59
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.28
Wall Street Target
$36.75
(+61.0%)
Revenue Growth (YoY)
278.7%
Share & Embed Analysis
Last updated: October 22, 2026 9:47 PM ET
Data refreshes hourly during market hours. Next update: 10:47 PM
Data refreshes hourly during market hours. Next update: 10:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VRDN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 49 HOLD |
|
TSHA
Taysha Gene Therapies Inc |
STRONG BUY
13 analysts |
$13 | 61 BUY |
|
TRVI
Trevi Therapeutics Inc |
STRONG BUY
11 analysts |
$28 | 69 BUY |
Advanced VRDN Option Strategies
Professional options setups generated by AI based on today's VRDN price and gamma walls.
